Table 2 Psychotropic medications used in maintenance treatmenta
rTMS + ADP | rTMS | ADP | Statistical values | |||
|---|---|---|---|---|---|---|
(n = 82) | (n = 91) | (n = 108) | χ 2 or t | d.f. | P | |
Antidepressants | ||||||
Paroxetine | ||||||
No. of patients (%) | 54 (65.9) | — | 87 (80.6) | 4.524 | 1 | 0.033 |
Dose ( ± SD, mg/day) | 20.1 ± 3.7 | — | 21.4 ± 4.5 | 1.857 | 139 | 0.065 |
Venlafaxine | ||||||
No. of patients (%) | 15 (18.3) | — | 19 (17.6) | 0.004 | 1 | 0.947 |
Dose ( ± SD, mg/day) | 132.1 ± 31.5 | — | 147.0 ± 16.5 | 2.018 | 32 | 0.085 |
Escitalopram | ||||||
No. of patients (%) | 6 (7.7) | — | 0 | — | — | — |
Dose ( ± SD, mg/day) | 10.0 (0) | — | 0 | — | — | — |
Fluoxetine | ||||||
No. of patients (%) | 3 (3.8) | — | 0 | — | — | — |
Dose ( ± SD, mg/day) | 23.3 (5.8) | — | 0 | — | — | — |
Sertraline | ||||||
No. of patients (%) | 2 (2.6) | — | 0 | — | — | — |
Dose ( ± SD, mg/day) | 100.0 (0) | — | 0 | — | — | — |
Anti-insomnia medicationsb | ||||||
Benzodiazepines, n (%) | 50 (61.0) | 64 (70.3) | 65 (60.2) | 2.570 | 2 | 0.277 |
Non-benzodiazepines, n (%) | 11 (14.1) | 19 (20.9) | 15 (14.9) | 1.771 | 2 | 0.412 |
